Dicyclomine Hydrochloride Capsules recall (Aurobindo Pharma USA Inc)
DrugClass IIOngoing
Summary: Aurobindo Pharma USA Inc is recalling Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC 59651-719-99. Reason: shortfill; reports of empty capsules.
What is being recalled
Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC 59651-719-99
Why
shortfill; reports of empty capsules.
How serious is it
Class II is the middle level: using or being exposed to this product may cause temporary or medically reversible health problems, and the chance of serious harm is remote.
Where it was sold
US Nationwide.
How to tell if yours is affected
Batch # DMC125018A, Exp Date: 07/2027.
What to do
Check the product name, lot number and expiration date on your package against the codes above. If they match, do not stop taking a prescription medicine without talking to your doctor or pharmacist first; ask them about a replacement. Return or dispose of the product as your pharmacy advises.
Recall facts
| Recall number | D-0733-2026 |
| Category | Drug |
| Agency | U.S. Food and Drug Administration (FDA) |
| Severity | Class II |
| Status | Ongoing |
| Recall started | July 23, 2026 |
| Reported | August 12, 2026 |
| Company | Aurobindo Pharma USA Inc |
| Company location | East Windsor, NJ, United States |
| Initiated by | Voluntary: Firm initiated |
| Quantity | 6,408 bottles distributed to market |
More recalls from Aurobindo Pharma USA Inc · all drug recalls · recalls from July 2026